Chronic pharyngitis may be reclassified into reproducible biological subgroups to improve targeted treatment strategiesNew ways to understand and treat long term throat irritation and infection

Frontiers in Medicine Published October 24, 2026 Study authors: Yao Sun, Zetong Hong, Yiming Guo, Haizhen Cui, Yueyao Jiang, Qian Yu DOI ↗ Editorial oversight: Dr. Julia Lee, PhD · Oncology, Genomics & Drug Development

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

Consider reclassifying chronic pharyngitis into biological subgroups to better address diverse underlying mechanisms.

This narrative review synthesizes various sources, including human observations and experimental data from other mucosal systems, to explore the mechanisms underlying chronic pharyngitis. The review highlights the complexity of the condition, noting that human clinical observations show substantial variation in anatomical sites, microbial findings, and immune organization. These variations suggest that the condition may not be a monolithic entity but rather a collection of distinct clinical presentations.

Key findings indicate that epithelial injury and the activation of shared inflammatory and stress-response pathways are central to the pathology. Additionally, the review notes that adaptive immune responses are highly context-dependent and that microbial community changes are most informative when linked to organism viability or host sensing. Sensory signaling may also contribute to patient symptoms independently of measurable inflammation.

Due to the lack of primary clinical trial data in this narrative synthesis, the evidence for specific treatment interventions is not established. However, the authors suggest that reclassifying chronic pharyngitis into reproducible biological subgroups could facilitate more precise mechanistic investigations. This approach may eventually support more tailored and effective clinical management for patients with varying underlying pathologies.

Chronic pharyngitis is a long-term condition that causes ongoing irritation in the throat. While many people experience these symptoms, the underlying causes can vary greatly from person to person. Researchers are looking at how the lining of the throat reacts to stress and injury.

Studies show that the body's immune system and the tiny organisms living in the throat play big roles in how a person feels. Some patients may have issues with their protective barriers, while others might have different types of bacteria causing problems. These differences mean that one treatment might work for some people but not for others.

Understanding these specific biological groups could help doctors give more personalized care. By looking at things like tissue repair and how the body senses pain, doctors can better identify why some cases are harder to treat. This approach aims to move away from a one-size-fits-all method for throat issues.

Future goals involve grouping patients based on their specific biological markers. This could lead to more effective treatments that target the exact cause of the irritation, such as specific immune responses or local infections. This shift could improve long-term comfort and health for those with chronic throat conditions.

What this means for you:

Grouping patients by their specific biological markers can help doctors provide more accurate treatments.

Common questions

Why is it hard to treat chronic pharyngitis?

Treatment can be difficult because human observations show a lot of variation in where the inflammation occurs and how different people respond. The review suggests that the condition might need to be grouped into different biological categories to help doctors provide more precise treatments for each person.

What causes the symptoms in chronic pharyngitis?

Symptoms may come from several sources. These include tissue damage, the activation of stress-response pathways, and sensory signaling. Interestingly, some sensory signals may cause symptoms even when there is not a lot of measurable inflammation present.

How does the immune system react to this condition?

The adaptive immune response in these cases appears to be strongly context dependent. This means the way the body's immune system reacts can change significantly depending on the specific environment and factors involved in the throat's inflammation.

Study Details

Study typeSystematic review

EvidenceLevel 1

PublishedOct 2026

View Original Abstract ↓

Chronic pharyngitis is a clinically heterogeneous condition in which persistent throat symptoms, visible mucosal abnormalities, and underlying biological processes do not necessarily coincide. This critical narrative review synthesizes evidence from human chronic pharyngitis, experimental injury models, adjacent upper-airway disorders, and other mucosal systems to examine how epithelial barrier function, innate and adaptive immunity, microbial ecology, sensory signaling, and tissue repair may contribute to disease persistence. Experimental studies identify epithelial injury and activation of shared inflammatory and stress-response pathways, while human observations highlight substantial variation in anatomical site, microbial findings, immune organization, and treatment response. Adaptive immune responses appear strongly context dependent; microbial community changes are most informative when linked to organism viability, metabolite production, host sensing, or colonization resistance; and sensory pathways may contribute to symptoms partly independently of measurable inflammation. We propose that persistent disease can arise through three overlapping routes: continued exposure, durable alteration of tissue responsiveness, and incomplete resolution or repair, with microbial and sensory processes acting as modifiers. This framework separates symptom improvement, biological target engagement, and durable restoration of tissue function as distinct therapeutic outcomes. Future studies should prioritize anatomically precise longitudinal cohorts, site-resolved single-cell and spatial profiling, functional perturbation in primary pharyngeal systems, and mechanism-informed trials with follow-up after treatment withdrawal. By linking clinical presentation to local biological function and recovery trajectories, chronic pharyngitis may be reclassified into reproducible biological subgroups that support more precise mechanistic investigation and treatment.

Chronic pharyngitis may be reclassified into reproducible biological subgroups to improve targeted treatment strategiesNew ways to understand and treat long term throat irritation and infection

Common questions

Study Details

First-line immune checkpoint inhibitor combinations improve overall survival in extensive-stage small-cell lung cancer

Immune checkpoint inhibitors combined with chemotherapy improve small cell lung cancer survival

Clinical research that matters. Delivered to your inbox.

Chronic pharyngitis may be reclassified into reproducible biological subgroups to improve targeted treatment strategiesNew ways to understand and treat long term throat irritation and infection

Common questions

Study Details

First-line immune checkpoint inhibitor combinations improve overall survival in extensive-stage small-cell lung cancer

Immune checkpoint inhibitors combined with chemotherapy improve small cell lung cancer survival

Clinical research that matters. Delivered to your inbox.

Related in Oncology

From Other Specialties